Samuray TUNCER, Halil Haldun EMİROĞLU, Melike EMIROĞLU, Osman Bülent ZÜLFIKAR, Rejin KEBUDI

Bilateral Cytomegalovirus Retinitis in a Child with Rhabdomyosarcoma

Reactivation of cytomegalovirus (CMV) leading to retinitis has been commonly reported in association with human immunodeficiency virus (HIV) infection or iatrogenic suppression of the immune system, including transplant recipients. Rhabdomyosarcoma (RMS) is the most common soft tissue malignancy in the pediatric age group, and alveolar histology is associated with unfavorable outcome. Presently described is case of RMS with alveolar histology in a 12-year-old male who developed CMV bilateral retinitis during prolonged period of neutropenic fever after 40 weeks of chemotherapy. He was diagnosed based on CMV-DNA polymerase chain reaction in blood and urine samples, and responded well to intravenous gancyclovir treatment. A high index of suspicion for reactivation of CMV leading to retinitis should be maintained and, if needed, investigated, not only in patients with HIV infection or transplant recipients, but also all patients who are iatrogenically immunosuppressed, including those who experience prolonged neutropenic fever due to lengthy courses of radiotherapy and chemotherapy

PDF

___

1. Wagle AM, Biswas J, Gopal L, Madhavan HN. Clinical profile and immunological status of cytomegalovirus retinitis in organ transplant recipients. Indian J Ophthalmol 2002;50(2):115-21.
2. Ince D, Demirag B, Vergin C, Olgun N. Posttransplant lymphoproliferative diseases during childhood: Review. Turkiye Klinikleri J Pediatr 2015;24(3):95-106.
3. Larochelle MB, Phan R, Craddock J, Abzug MJ, Curtis D, Robinson CC, et al. Cytomegalovirus retinitis in pediatric stem cell transplants: report of a recent cluster and the development of a screening protocol. Am J Ophthalmol 2017;175(1):8-15.
4. Kuo IC, Kempen JH, Dunn JP, Vogelsang G, Jabs DA. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol 2004;138(3):338-46.
5. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999;341(5):342-52.
6. Raney RB, Maurer HM, Anderson JR, Andrassy RJ, Donaldson SS, Qualman SJ, et al. The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols. Sarcoma 2001;5(1):9-15.
7. Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992;5(11):1069-74.
8. Ausayakhun S, Keenan JD, Ausayakhun S, Jirawison C, Khouri CM, Skalet AH, et al. Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand. Am J Ophthalmol 2012;153(5):923- 31.
9. Baumal CR, Levin AV, Read SE. Cytomegalovirus retinitis in immunosuppressed children. Am J Ophthalmol 1999;127(5):550-8.
10.Huynh N, Daniels AB, Kohanim S, Young LH. Medical treatment for cytomegalovirus retinitis. Int Ophthalmol Clin 2011;51(4):93-103.
11.Tawse KL, Baumal CR. Intravitreal foscarnet for recurring CMV retinitis in a congenitally infected premature infant. J AAPOS 2014;18(1):78-80.